AMRX — Amneal Pharmaceuticals Share News
0.000.00%
Last trade - 00:00- $5.17bn
- $7.69bn
- $3.02bn
Amneal rises after J.P. Morgan upgrades to 'neutral' on strength in generics unit
U.S. RESEARCH ROUNDUP- Broadcom, Costco Wholesale, Saia
Brief: Amneal And Shilpa Announce U.S. FDA Approval Of Boruzu™
Brief: Amneal Receives FDA Approval for Propofol Injectable Emulsion Single Dose Vials
U.S. STOCKS ON THE MOVE-Revance Therapeutics, Insulet, StepStone
U.S. STOCKS ON THE MOVE-Synchrony, Grindr, Blend Labs
Amneal Pharmaceuticals Inc reports results for the quarter ended in June - Earnings Summary
Amneal Pharmaceuticals rises on annual revenue forecast raise
Brief: Amneal Says Raising 2024 Full Year Guidance
Brief: Amneal Pharmaceuticals Says Crexont Commercial Launch Planned In September 2024
Amneal Pharmaceuticals Inc expected to post earnings of 14 cents a share - Earnings Preview
Brief: Amneal Receives US FDA Approval For Potassium Phosphates Injection IV Bags
Amneal, US FTC win order removing Teva inhaler patents from FDA list
Drugmaker Amneal agrees to $270 million U.S. opioid settlement
Amneal Pharmaceuticals Inc reports results for the quarter ended in March - Earnings Summary
Amneal Pharmaceuticals Inc expected to post earnings of 9 cents a share - Earnings Preview
U.S. STOCKS ON THE MOVE-Globe Life, EQT, Ribbon Communications
U.S. STOCKS ON THE MOVE-MSCI, Globe Life, EQT Corp
U.S. STOCKS ON THE MOVE-Biogen, Humana, gold miners